News

Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal to develop a first-in-class cyclin inhibitor that…
Read More...

Arda Therapeutics, a pioneer in targeted cell depletion therapies for chronic diseases, announced the successful completion of a $43 million Series A financing round. The round was led…
Read More...

Biogen announced that felzartamab, an investigational anti-CD38 monoclonal antibody, has received Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration (FDA)…
Read More...

insitro, a machine learning-enabled drug discovery and development company, announced the execution of three strategic agreements with Eli Lilly and Company (Lilly) focused on advancing…
Read More...

Teva Pharmaceutical Industries Ltd. announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted, and the European Medicines Agency (EMA) has validated,…
Read More...

Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI 456906), a dual glucagon/GLP-1 receptor…
Read More...

Bayer and MOMA Therapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, announced that they have entered…
Read More...

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune,…
Read More...

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. and mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud…
Read More...

National Resilience, Inc., a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, proudly announces that its subsidiary, Resilience…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Opdivo  (nivolumab) for the treatment of adult patients with resectable (tumors ≥4 cm or node…
Read More...

Recordati announces an agreement with Sanofi to acquire the global rights to Enjaymo (sutimlimab), a biologic which is the only approved targeted product for the treatment of cold…
Read More...

Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the treatment of…
Read More...

Charles River Laboratories International, Inc. announced an agreement with H. Lundbeck A/S (Lundbeck) to utilize Logica to progress critical brain disease research. “We are excited…
Read More...

Arcus Biosciences, Inc. announced a clinical trial collaboration agreement with AstraZeneca to evaluate casdatifan (AB521), Arcus’s investigational HIF-2a inhibitor, in combination with…
Read More...

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced the successful completion of its acquisition of a…
Read More...

ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that it has entered into a clinical trial collaboration and supply agreement with MSD (a…
Read More...

Gilead Sciences, Inc. announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six pharmaceutical manufacturers to make and sell generic lenacapavir,…
Read More...

ImmunoPrecise Antibodies Ltd., an AI-driven biotherapeutic research and technology company, and Biotheus Inc. (Biotheus), a clinical-stage biotech company dedicated to the discovery and…
Read More...

GenEditBio Limited, a biotech company co-founded by Prof. ZHENG Zongli from the City University of Hong Kong that focuses on precision genome editing to provide affordable "precision…
Read More...